Topics

Solentim Company Profile

18:31 EST 24th January 2020 | BioPortfolio

Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedicated to the development of innovative tools to shorten steps in the upstream cell line development workflow and facilitate cell line scale-up. The Cell Metric™ product range consists of bio-analytical imaging stations for clone screening and proof of monoclonality, clone growth and stability measurements. To find more information visit www.solentim.com


News Articles [10 Associated News Articles listed on BioPortfolio]

Solentim wins place in Deloitte UK Technology Fast 50

Solentim named as one of the top 50 fastest growing UK technologies companies of 2018

Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies

A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million ...

Solentim Wins Two Queen’s Awards for Enterprise

Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation Wimborne, UK, 8th October 2018 / Sciad Newswire / Solentim...

Dr Mark Truesdale joins Solentim as new Chief Marketing Officer

Bournemouth, UK, 1st October 2019 / Sciad Newswire / Solentim, the global leader in cell line development (CLD) instrumentation, is delighted to announce that Dr Mark Truesdale will join the Compan...

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Bournemouth, UK and Newark, CA, USA, 14th January 2019 / Sciad Newswire / Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a tec...

Solentim and SAL Scientific announce partnership for novel growth supplements in cell line development

Bournemouth, UK, and Fordingbridge, UK, 25th April 2019 / Sciad Newswire / Solentim, the global leader in cell line development (CLD) imaging instrumentation, and SAL Scientific, a leading provider...

Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

Dublin, Ireland and Bournemouth, UK, 21st February 2019 / Sciad Newswire / Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line devel...

Dr Mark Truesdale joins Solentim as chief marketing officer

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Solentim

Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedi...

More Information about "Solentim" on BioPortfolio

We have published hundreds of Solentim news stories on BioPortfolio along with dozens of Solentim Clinical Trials and PubMed Articles about Solentim for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Solentim Companies in our database. You can also find out about relevant Solentim Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record